RSS Feeds
Search

In-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Systemic Lupus Erythematosus Therapy Area Pipeline Report
Nov 2010 - 240 pages - $1,495
FDA ends the 50-year long wait for Lupus patients - Benlysta set to become the next blockbuster
Mar 2011 - 5 pages - $500
Lupus Nephritis - Pipeline Review, H2 2011
Oct 2011 - 56 pages - $500
Lupus Nephritis - Pipeline Review, Q1 2011
Mar 2011 - 42 pages - $500
R&D Trends: Systemic Lupus Erythematosus - Benlysta’s FDA approval provides hope for disease treatment, future trial design, and other pipeline candidates
May 2011 - 62 pages - $3,800
Deals and alliances in dermatological diseases
Jun 2006 - 434 pages - $2,495
Solid Tumors - Pipeline Review, Q3 2011
Jul 2011 - 372 pages - $500
Labor and Delivery Therapy Area Pipeline Report
Nov 2010 - 185 pages - $1,495
Systemic Lupus Erythematosus - Pipeline Review, Q1 2011
Feb 2011 - 75 pages - $500
Product Profiles: Systemic Lupus Erythematosus – Benlysta approval brings lessons and hope to market
Jun 2011 - 117 pages - $11,400
More Related Market Research Reports >>>

Your selection

Industry sector
Drug delivery del
Otic del
Solid del
Therapeutic target
Dermatological del
Lupus del
Development phase
Early Stage del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us